LEADER 03801nam 22005895 450 001 9910369935903321 005 20200702203053.0 010 $a3-030-24131-9 024 7 $a10.1007/978-3-030-24131-5 035 $a(CKB)4100000009758977 035 $a(DE-He213)978-3-030-24131-5 035 $a(MiAaPQ)EBC5973798 035 $a(PPN)269147225 035 $a(EXLCZ)994100000009758977 100 $a20191105d2020 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBehçet Syndrome /$fedited by Yusuf Yazici, Gulen Hatemi, Emire Seyahi, Hasan Yazici 205 $a2nd ed. 2020. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2020. 215 $a1 online resource (XVI, 328 p. 98 illus., 75 illus. in color.) 311 $a3-030-24130-0 327 $aChapter 1. Introduction -- Chapter 2. Disease Definition and Epidemiology -- Chapter 3. Skin Mucosa Involvement and the Pathergy Reaction -- Chapter 4. Eye Disease -- Chapter 5. Nervous System Disease -- Chapter 6. Lung Disease -- Chapter 7. Peripheral Vascular and Cardiac Disease -- Chapter 8. Locomotor System Disease -- Chapter 9. Gastrointestinal Involvement -- Chapter 10. Other Clinical Aspects -- Chapter 11. Pediatric Behçet's Syndrome -- Chapter 12. Histopathology -- Chapter 13. Behçet?s Syndrome and Microbes -- Chapter 14. Thrombophilia in Behçet?s Syndrome -- Chapter 15. Genetics and Epigenetics -- Chapter 16. Disease Mechanisms -- Chapter 17. Prognosis -- Chapter 18. Disease Assessment -- Chapter 19. Management -- Chapter 20. The Patient?s View -- Chapter 21. Future Research Considerations. 330 $aThe expanded second edition of this important work provides an up-to-date and comprehensive overview of Behçet syndrome. New and updated chapters focus on recent advances in the areas of pathogenesis, the microbiome, genetics and epigenetics, clustering of symptoms, disease assessment and new treatment options. The book examines how these developments have changed the way physicians approach diagnosis, treatment, and management of Behçet patients. It also analyzes the wide variety of clinical manifestations of the disease including mucocutaneous lesions, intraocular inflammation, central nervous system involvement, deep vein thrombosis and other forms of major vascular disease. Building on the success of its predecessor, the Second Edition of Behçet Syndrome is an invaluable resource for physicians, residents, fellows, and graduate students in rheumatology, dermatology, ophthalmology, neurology, gastroenterology, and internal medicine. 606 $aRheumatology 606 $aDermatology 606 $aOphthalmology 606 $aRheumatology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33170 606 $aDermatology$3https://scigraph.springernature.com/ontologies/product-market-codes/H1900X 606 $aOphthalmology$3https://scigraph.springernature.com/ontologies/product-market-codes/H44004 615 0$aRheumatology. 615 0$aDermatology. 615 0$aOphthalmology. 615 14$aRheumatology. 615 24$aDermatology. 615 24$aOphthalmology. 676 $a616.723 676 $a616.97 702 $aYazici$b Yusuf$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aHatemi$b Gulen$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aSeyahi$b Emire$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aYazici$b Hasan$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910369935903321 996 $aBehçet Syndrome$92195559 997 $aUNINA